Sylvester Comprehensive Cancer Center

E-mail a Friend

Rakesh Singal, M.D.

General Information

Rakesh  Singal, M.D.

Languages

  • English
  • Hindi

Certifications

  • American Board of Internal Medicine
  • American Board of Internal Med-Medical Oncology

Specialties

  • Hematology/Oncology - Internal Medicine
  • Internal Medicine

Roles

  • Associate Professor of Medicine

Clinical Interests

Genitourinary malignancies, prostate cancer, bladder cancer

Research Interests

Prostate cancer, epigenetics, transcriptional regulation, DNA methylation, chromatin structure, biomarkers

Awards

South Florida Super Doctors
Advanced Research Career Development Award
Awarded by the Minneapolis Society of Internal Medicine and Minnesota Medical Foundation
Awarded by DNA Methylation Society
University of Minnesota

Education

Graduate
Maulana Azad Medical College
Residency
MetroHealth Medical Center
Fellowship
University of Minnesota

Publications

  • Singal R, Ramachandran K, Gordian E, Quintero C, Zhao W, Reis IM. Phase I/II Study of Azacitidine, Docetaxel, and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Therapy. Clin Genitourin Cancer. 2014 Aug 1. pii: S1558-7673(14)00155-4. doi: 10.1016/j.clgc.2014.07.008. [Epub ahead of print]
  • Ramachandran K, Singal R. DNA methylation and field cancerization. Epigenomics. 2012 Jun;4(3):243-5
  • Gordian E, Ramachandran K, Reis IM, Manoharan M, Soloway MS, Singal R. Serum free circulating DNA is a useful biomarker to distinguish benign versus malignant prostate disease. Cancer Epidemiol Biomarkers Prev. 2010;19:1984-1991.

E-mail a Friend